BioHelix Corp.

BioHelix Corp. is a biotechnology startup founded in 2004 with a mission to enhance healthcare quality by developing simple molecular diagnostic tests for rapid medical intervention. The company aims to achieve this through its proprietary isothermal Helicase Dependent Amplification (HDA) technology and instrument-free detection device, enabling broader access to molecular diagnostic tests with minimal capital expenditure. BioHelix Corp. is focused on empowering middle-tier hospital labs and point-of-care facilities with cost-effective solutions, with an eye towards personalized medicine. The company has established strong R&D capabilities and partnerships with industry leaders in the in vitro diagnostics (IVD) field. Currently, there is no public information available on the company's last investment and the last investment investors.